Immune Dysregulation and Vaccine Response in Rare Blood Cancers: Insights from a Pilot Study
OLP Admin
The Reeves lab recently published a study in eJHaem exploring the immune system in patients with myeloproliferative neoplasms (MPNs), a type of rare blood cancer. These patients are particularly vulnerable to infections and often require immunosuppressive drugs, highlighting the importance of effective vaccination. Our study found that MPN patients exhibit significant changes in immune cells, […] The post Immune Dysregulation and Vaccine Response in Rare Blood Cancers: Insights from a Pilot Stud